Answers are grounded in this paper and cite their sources.
ANKRD26-related thrombocytopenia is an inherited marrow disorder characterized by impaired megakaryocytic maturation and predisposition to myeloid neoplasia. Recent data have expanded its phenotypic spectrum to include non–Langerhans cell histiocytic proliferations; however, an association with Langerhans cell histiocytosis (LCH) has not been documented. We report a 7-month-old male infant with anemia, thrombocytopenia, hepatosplenomegaly, and diffuse seborrheic dermatitis–like skin lesions who was found to harbor a germline ANKRD26 mutation. Bone marrow examination demonstrated megakaryocytic dysplasia with paratrabecular clustering and an interstitial histiocytic proliferation composed of CD68-positive, S100/CD1a/Langerin-negative cells lacking BRAF V600E mutation, consistent with non–Langerhans cell histiocytosis. In contrast, skin biopsy revealed a morphologically and immunophenotypically distinct histiocytic infiltrate with grooved nuclei, expression of CD1a, Langerin, and S100, and presence of BRAF V600E mutation, confirming LCH. Whole-body imaging demonstrated multisystem involvement. The coexistence of 2 biologically distinct histiocytic proliferations in separate tissue compartments supports a germline–somatic interaction, wherein ANKRD26-associated myeloid dysregulation provides a permissive background for secondary oncogenic events. This case underscores the diagnostic importance of integrated morphologic, immunophenotypic, and tissue-specific molecular evaluation in pediatric histiocytic disorders.
No takes yet. Share an insight, caveat, or question.
Kiruthiga et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: